Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Optimer Pharmaceuticals Inc OPTR

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:OPTR)

Stellar Biotechnologies Appoints Tessie Che, Ph.D. to Board of Directors

Marketwired September 25, 2013

SHAREHOLDER ALERT: Law Firm Brower Piven Announces That a Class Action Lawsuit Has Been Filed in Connection With the Optimer Pharmaceuticals, Inc. Proposed Buyout Alleging That Optimer's Directors Have Breached Their Fiduciary Duties to Shareholders -- OPTR

Globe Newswire August 14, 2013

Harwood Feffer LLP Announces Investigation of Optimer Pharmaceuticals, Inc.

PR Newswire August 12, 2013

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Optimer Pharmaceuticals, Inc.

Business Wire August 12, 2013

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Optimer Pharmaceuticals, Inc. - OPTR

PR Newswire August 5, 2013

Optimer Pharmaceuticals, Inc. (OPTR) Investor Lawsuit to Halt Takeover Announced by Shareholders Foundation

Globe Newswire August 5, 2013

Investigations into Proposed Buyouts of Optimer Pharmaceuticals, Inc., Trius Therapeutics, Inc. and Maidenform Brands, Inc. Announced by Holzer Holzer & Fistel, LLC

Business Wire August 1, 2013

OPTIMER PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Investigates Possible Breaches of Fiduciary Duty by Board of Optimer Pharmaceuticals, Inc. in Connection with Sale of Company to Cubist Pharmaceuticals, Inc.

PR Newswire August 1, 2013

Ryan & Maniskas, LLP Announces Investigation of Optimer Pharmaceuticals, Inc.

PR Newswire August 1, 2013

Opinion & Analysis (NDAQ:OPTR)

No current opinion is available.

Bullboard Posts (NDAQ:OPTR)

oh look at that

oppenheimer raised to $19.
conspiTheory - June 13, 2011

did i say

i wanted to sell at 14.5. did i do it?NO and i pay the price bam. but this is ok they needed to excercise their put at 12.5 so i guess it...
conspiTheory - June 12, 2011

RE: still in

if it does not go up next week i will sell and watch. i guess only THEY want to screw the option people so it might stay around
conspiTheory - June 4, 2011

still in

even though i thought to sell @14.50.
conspiTheory - May 28, 2011

am in

lets see how the play will be done. will they keep it at this price until May. not too many institution and analysts are beating each...
conspiTheory - March 31, 2011

Optimer Pharmaceuticals, Inc. (OPTR) has a tradabl

Optimer Pharmaceuticals, Inc. (OPTR) has a tradable event on April 5th, 2011, an FDA Advisory Committee Meeting for Fidaxomicin their...
JJSNYC - March 25, 2011